Early Access

10-QPeriod: Q1 FY2022

CME GROUP INC. Quarterly Report for Q1 Ended Mar 31, 2022

Filed May 4, 2022For Securities:CME

Summary

CME Group Inc. reported strong financial results for the first quarter of 2022, demonstrating robust revenue growth and improved profitability. Total revenues increased by 7% year-over-year to $1.35 billion, primarily driven by a significant 13% rise in clearing and transaction fees to $1.14 billion. This growth in core business revenue was fueled by a 21% increase in total contract volume, with notable surges in interest rate and equity index products, reflecting heightened market volatility. The company also saw a 5% increase in market data and information services revenue. Despite increased revenues, total expenses saw a decrease of 8% to $487.5 million, leading to an expansion in operating margin from 57.9% to 63.8%. This reduction in expenses was mainly due to lower compensation and benefits costs, partly offset by an increase in licensing and other fee agreements. Net income attributable to CME Group grew by a substantial 24% to $711.0 million, resulting in diluted earnings per common share of $1.95, up from $1.60 in the prior year's quarter. The company also maintained a strong liquidity position and declared a quarterly dividend of $1.00 per share.

Financial Statements
Beta
Revenue$1.35B
Operating Expenses$487.50M
Operating Income$859.10M
Net Income$711.00M
EPS (Basic)$1.96
EPS (Diluted)$1.95
Shares Outstanding (Basic)358.61M
Shares Outstanding (Diluted)359.18M

Key Highlights

  • 1Total revenues increased by 7% to $1.35 billion in Q1 2022 compared to Q1 2021.
  • 2Clearing and transaction fees, the primary revenue driver, grew by 13% to $1.14 billion.
  • 3Total contract volume surged by 21% year-over-year, indicating increased market activity and volatility.
  • 4Interest rate and equity index products showed significant volume increases (21% and 30% respectively), driven by macroeconomic factors and geopolitical events.
  • 5Operating expenses decreased by 8% to $487.5 million, contributing to an improved operating margin.
  • 6Net income attributable to CME Group increased by 24% to $711.0 million.
  • 7Diluted earnings per share rose to $1.95 from $1.60 in the prior year's quarter.

Frequently Asked Questions